Evaluation of the Protective Effects of Quercetin, Rutin, Naringenin, Resveratrol and Trolox Against Idarubicin-Induced DNA Damage

PURPOSE. Idarubicin is a synthetic anthracycline anticancer drug widely used in the treatment of some hematological malignancies. The studies in our laboratory have clearly demonstrated that idarubicin can undergo reductive bioactivation by NADPH-cytochrome P450 reductase to free radicals with resul...

詳細記述

書誌詳細
主要な著者: Haydar Çelik, Emel Arinç
フォーマット: 論文
言語:English
出版事項: Frontiers Media S.A. 2010-07-01
シリーズ:Journal of Pharmacy & Pharmaceutical Sciences
オンライン・アクセス:https://journals.library.ualberta.ca/jpps/index.php/JPPS/article/view/7167